SLC22A5 and cardiomyopathy: Mutations in the gene encoding OCTN2, SLC22A5, can impair fatty acid metabolism and lead to systemic primary carnitine deficiency (SPCD, OMIM 212140)8, an autosomal recessive disorder whose clinical manifestations include cardiomyopathy, hypoglycemia, chronic muscle weakness and liver dysfunction9.